tm
Seeing Is Believing
tm
Seeing Is Believing
GPCR is currently covered by 7 analysts with an average price target of $59.56. This is a potential upside of $40.03 (204.97%) from yesterday's end of day stock price of $19.53.
Structure Therapeutics American Depositary Shares's activity chart (see below) currently has 2 price targets and 30 ratings on display. The stock rating distribution of GPCR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 19.05% with an average time for these price targets to be met of 41.43 days.
Highest price target for GPCR is $89, Lowest price target is $65, average price target is $83.57.
Most recent stock forecast was given by PRAKHAR AGRAWAL from CANTOR FITZGERALD on 23-Jun-2025. First documented stock forecast 28-Feb-2023.
Currently out of the existing stock ratings of GPCR, 27 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$65
$45.99 (241.93%)
$65
24 days ago
(23-Jun-2025)
0/11 (0%)
$42.9 (194.12%)
Buy
$89
$69.99 (368.17%)
$91
24 days ago
(23-Jun-2025)
0/7 (0%)
$66.9 (302.71%)
Buy
$80
$60.99 (320.83%)
$80
6 months 28 days ago
(19-Dec-2024)
0/2 (0%)
$50.03 (166.93%)
Buy
$100
$80.99 (426.04%)
$83
1 years 1 months 10 days ago
(07-Jun-2024)
1/3 (33.33%)
$46.93 (88.43%)
121
Buy
$93
$73.99 (389.22%)
$58
1 years 8 months 20 days ago
(27-Oct-2023)
1/2 (50%)
$24.83 (36.42%)
68
What is GPCR (Structure Therapeutics American Depositary Shares) average time for price targets to be met?
Which analyst has the current highest performing score on GPCR (Structure Therapeutics American Depositary Shares) with a proven track record?
Which analyst has the current lower performing score on GPCR (Structure Therapeutics American Depositary Shares) with a proven track record?
Which analyst has the most public recommendations on GPCR (Structure Therapeutics American Depositary Shares)?
Which analyst is the currently most bullish on GPCR (Structure Therapeutics American Depositary Shares)?
Which analyst is the currently most reserved on GPCR (Structure Therapeutics American Depositary Shares)?
